Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for Agilon Health (AGL) over the last 5 years, with FY2024 value amounting to $411.0 million.

  • Agilon Health's Shares Outstanding (Diluted Average) rose 69.83% to $414.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $414.5 million, marking a year-over-year increase of 69.83%. This contributed to the annual value of $411.0 million for FY2024, which is 50.11% up from last year.
  • According to the latest figures from FY2024, Agilon Health's Shares Outstanding (Diluted Average) is $411.0 million, which was up 50.11% from $408.9 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Shares Outstanding (Diluted Average) registered a high of $411.0 million during FY2024, and its lowest value of $323.5 million during FY2020.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $408.2 million (2022), whereas its average is $384.9 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first surged by 1529.36% in 2021, then increased by 18.69% in 2023.
  • Agilon Health's Shares Outstanding (Diluted Average) (Annual) stood at $323.5 million in 2020, then rose by 15.29% to $372.9 million in 2021, then rose by 9.44% to $408.2 million in 2022, then rose by 0.19% to $408.9 million in 2023, then increased by 0.5% to $411.0 million in 2024.
  • Its last three reported values are $411.0 million in FY2024, $408.9 million for FY2023, and $408.2 million during FY2022.